Skip to Content

LBH 15 mg (Farydak 15 mg)

Generic Name: panobinostat

This pill with imprint "LBH 15 mg" is Orange, Capsule-shape and has been identified as Farydak 15 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Farydak is used in the treatment of multiple myeloma and belongs to the drug class histone deacetylase inhibitors. Farydak 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for LBH 15 mg

Farydak

Generic Name:
panobinostat
Imprint:
LBH 15 mg
Strength:
15 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Histone deacetylase inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0651

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide